Core Viewpoint - The article discusses the tax exemption policy for land use in agricultural production, highlighting that land directly used for agriculture, forestry, animal husbandry, and fishery is exempt from urban land use tax [6][7]. Group 1: Tax Exemption Policy - Agricultural production land, including land used for planting, breeding, and feeding, is exempt from urban land use tax [6][7]. - The exemption does not apply to land used for processing agricultural products or for living and office purposes [7]. Group 2: Relevant Regulations - The policy is based on the "Interim Regulations on Urban Land Use Tax" and related notifications from the State Administration of Taxation [8].

Core Viewpoint - The ownership transfer of Aoyang Health (002172.SZ) to Zhangjiagang Economic and Technological Development Zone Management Committee has been confirmed, aligning with previous market rumors [2][3]. Group 1: Ownership Transfer Details - Aoyang Health's controlling shareholder plans to transfer 20% of its shares to a company under Zhangjiagang Economic and Technological Development Zone Management Committee for a total price of 592 million yuan, while also relinquishing voting rights for an additional 5% of shares [2][3]. - The share transfer will be executed at a price of 3.87 yuan per share, which is a 10% discount compared to the price before the suspension of trading [3]. Group 2: New Management and Investment Focus - The new controlling entity, Yuesheng Technology, is led by a post-90s investment manager, who is expected to steer Aoyang Health towards new productive forces [5]. - Zhangjiagang Economic and Technological Development Zone Management Committee oversees around 30 core enterprises, focusing on traditional and emerging industries, including new energy and artificial intelligence [5]. Group 3: Financial Challenges - Aoyang Health has been facing high debt levels, with an asset-liability ratio exceeding 90% and interest-bearing debt ratio over 40% since 2021 [6]. - The company reported a significant loss of 1.03 billion yuan in 2021 due to asset impairment and poor performance in its healthcare segment [6]. - As of mid-2025, Aoyang Health had only 462 million yuan in cash against short-term borrowings of 646 million yuan, indicating a precarious financial position [6]. Group 4: Performance Commitments - The new management has set performance targets, requiring Aoyang Health to achieve a net profit of no less than 30 million yuan annually from 2025 to 2027, along with a minimum net cash flow from operating activities of 60 million yuan in 2025 [8]. - Previous cash flow figures for 2024 and the first half of 2025 were significantly below these targets, raising concerns about the company's ability to meet the new performance commitments [8].

Group 1 - Jiangsu Woyang Automatic Control Technology Co., Ltd. and Jiangsu Woyang Intelligent Technology Research Co., Ltd. have applied for a patent for a "coaxial dual-valve core magnetorheological valve" [1] - The patent features a design that includes two valve core components arranged coaxially, allowing for independent magnetic fields and fluid control areas, enhancing control precision and response speed [1] - The valve can handle different fluids or fluid states simultaneously, and if one valve core fails, the other can still operate normally, making it suitable for high dynamic demand applications [1] Group 2 - Jiangsu Woyang Automatic Control Technology Co., Ltd. was established in 2001, located in Xuzhou, with a registered capital of 1,116.38 million RMB [2] - The company has invested in 21 enterprises and participated in 571 bidding projects, holding 470 patents and 23 trademark registrations [2] - Jiangsu Woyang Intelligent Technology Research Co., Ltd. was founded in 2024, also in Xuzhou, with a registered capital of 10 million RMB and holds 21 patents [2]

Core Viewpoint - The first loss compensation insurance for shared scientific research instruments has been implemented in Suzhou, addressing long-standing issues related to equipment damage liability, thereby encouraging the sharing of high-end research instruments [2][3]. Group 1: Insurance Implementation - The insurance provides over 4 million yuan in risk coverage for large shared scientific research equipment at Suzhou University of Science and Technology [2]. - The insurance scheme integrates a "sharing economy + technology insurance" model, covering risks from design defects, installation errors, and operational mistakes [3]. Group 2: Impact on Research Institutions - The Suzhou University of Science and Technology has been providing technical support services for medical device and raw material R&D, owning high-end research instruments valued at over 10 million yuan [2]. - The insurance alleviates concerns about equipment damage, enabling the institution to fully utilize high-end equipment for comprehensive testing services [3]. Group 3: Future Directions - The municipal science and technology department plans to collaborate with instrument management departments, universities, and maintenance units to promote the use of more scientific instruments outside laboratories [3].